Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn

Hiroshi Yagi, Alejandro Soto-Gutierrez, Yuukou Kitagawa, Arno W. Tilles, Ronald G. Tompkins, Martin L. Yarmush

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Bone marrow mesenchymal stromal cells (MSCs) suppress immune cell responses and have beneficial effects in various inflammatory-related immune disorders. A therapeutic modality for systemic inflammation and its consequences is not available yet. Thus, this work investigates the therapeutic effects of MSCs in injury models induced by lipopolysaccharide (LPS) or burn. Gene expression was analyzed in MSCs when exposed to inflammatory serum from injured animals and it showed remarkable alterations compared to normal culture. In addition, injured animals were transplanted intramuscularly with MSCs. Forty-eight hours after cell transplantation, kidney, lung, and liver were analyzed for infiltration of inflammatory cells and TUNEL-expressing cells. Results showed that MSCs attenuate injury by reducing the infiltration of inflammatory cells in various target organs and by reducing cell death. These data suggest that MSCs emerge as key regulators of immune/inflammatory responses in vivo and as attractive candidates for cell-based treatments for systemic inflammatory-based disorders.

Original languageEnglish
Pages (from-to)823-830
Number of pages8
JournalCell Transplantation
Volume19
Issue number6-7
DOIs
Publication statusPublished - 2010

Fingerprint

Mesenchymal Stromal Cells
Infiltration
Lipopolysaccharides
Bone
Animals
Wounds and Injuries
Cell death
Gene expression
Liver
Immune System Diseases
Cell Transplantation
In Situ Nick-End Labeling
Therapeutic Uses
Cell Death
Inflammation
Kidney
Gene Expression
Lung
Therapeutics
Serum

Keywords

  • Anti-inflammation
  • Antiapoptosis
  • Burn
  • Lipopolysaccharide (LPS)
  • Multiple organ injury
  • Sepsis
  • Systemic inflammatory response syndrome (SIRS)

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. / Yagi, Hiroshi; Soto-Gutierrez, Alejandro; Kitagawa, Yuukou; Tilles, Arno W.; Tompkins, Ronald G.; Yarmush, Martin L.

In: Cell Transplantation, Vol. 19, No. 6-7, 2010, p. 823-830.

Research output: Contribution to journalArticle

Yagi, Hiroshi ; Soto-Gutierrez, Alejandro ; Kitagawa, Yuukou ; Tilles, Arno W. ; Tompkins, Ronald G. ; Yarmush, Martin L. / Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. In: Cell Transplantation. 2010 ; Vol. 19, No. 6-7. pp. 823-830.
@article{f2bcb228a0834f62a9c990b31ed59fdb,
title = "Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn",
abstract = "Bone marrow mesenchymal stromal cells (MSCs) suppress immune cell responses and have beneficial effects in various inflammatory-related immune disorders. A therapeutic modality for systemic inflammation and its consequences is not available yet. Thus, this work investigates the therapeutic effects of MSCs in injury models induced by lipopolysaccharide (LPS) or burn. Gene expression was analyzed in MSCs when exposed to inflammatory serum from injured animals and it showed remarkable alterations compared to normal culture. In addition, injured animals were transplanted intramuscularly with MSCs. Forty-eight hours after cell transplantation, kidney, lung, and liver were analyzed for infiltration of inflammatory cells and TUNEL-expressing cells. Results showed that MSCs attenuate injury by reducing the infiltration of inflammatory cells in various target organs and by reducing cell death. These data suggest that MSCs emerge as key regulators of immune/inflammatory responses in vivo and as attractive candidates for cell-based treatments for systemic inflammatory-based disorders.",
keywords = "Anti-inflammation, Antiapoptosis, Burn, Lipopolysaccharide (LPS), Multiple organ injury, Sepsis, Systemic inflammatory response syndrome (SIRS)",
author = "Hiroshi Yagi and Alejandro Soto-Gutierrez and Yuukou Kitagawa and Tilles, {Arno W.} and Tompkins, {Ronald G.} and Yarmush, {Martin L.}",
year = "2010",
doi = "10.3727/096368910X508942",
language = "English",
volume = "19",
pages = "823--830",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "6-7",

}

TY - JOUR

T1 - Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn

AU - Yagi, Hiroshi

AU - Soto-Gutierrez, Alejandro

AU - Kitagawa, Yuukou

AU - Tilles, Arno W.

AU - Tompkins, Ronald G.

AU - Yarmush, Martin L.

PY - 2010

Y1 - 2010

N2 - Bone marrow mesenchymal stromal cells (MSCs) suppress immune cell responses and have beneficial effects in various inflammatory-related immune disorders. A therapeutic modality for systemic inflammation and its consequences is not available yet. Thus, this work investigates the therapeutic effects of MSCs in injury models induced by lipopolysaccharide (LPS) or burn. Gene expression was analyzed in MSCs when exposed to inflammatory serum from injured animals and it showed remarkable alterations compared to normal culture. In addition, injured animals were transplanted intramuscularly with MSCs. Forty-eight hours after cell transplantation, kidney, lung, and liver were analyzed for infiltration of inflammatory cells and TUNEL-expressing cells. Results showed that MSCs attenuate injury by reducing the infiltration of inflammatory cells in various target organs and by reducing cell death. These data suggest that MSCs emerge as key regulators of immune/inflammatory responses in vivo and as attractive candidates for cell-based treatments for systemic inflammatory-based disorders.

AB - Bone marrow mesenchymal stromal cells (MSCs) suppress immune cell responses and have beneficial effects in various inflammatory-related immune disorders. A therapeutic modality for systemic inflammation and its consequences is not available yet. Thus, this work investigates the therapeutic effects of MSCs in injury models induced by lipopolysaccharide (LPS) or burn. Gene expression was analyzed in MSCs when exposed to inflammatory serum from injured animals and it showed remarkable alterations compared to normal culture. In addition, injured animals were transplanted intramuscularly with MSCs. Forty-eight hours after cell transplantation, kidney, lung, and liver were analyzed for infiltration of inflammatory cells and TUNEL-expressing cells. Results showed that MSCs attenuate injury by reducing the infiltration of inflammatory cells in various target organs and by reducing cell death. These data suggest that MSCs emerge as key regulators of immune/inflammatory responses in vivo and as attractive candidates for cell-based treatments for systemic inflammatory-based disorders.

KW - Anti-inflammation

KW - Antiapoptosis

KW - Burn

KW - Lipopolysaccharide (LPS)

KW - Multiple organ injury

KW - Sepsis

KW - Systemic inflammatory response syndrome (SIRS)

UR - http://www.scopus.com/inward/record.url?scp=77958608856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958608856&partnerID=8YFLogxK

U2 - 10.3727/096368910X508942

DO - 10.3727/096368910X508942

M3 - Article

C2 - 20573305

AN - SCOPUS:77958608856

VL - 19

SP - 823

EP - 830

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 6-7

ER -